Do anti-platelet drugs improve duration of continuous renal replacement therapy? A retrospective cohort study in cardiac ICU patients

CONCLUSION: This study indicates that systemic anti-platelet therapy can provide additional support in critical patients undergoing CRRT even with or without anti-coagulant therapy. However, the increase in CRRT filter life was more profound in patients who were on anti-platelet/s and also received anti-coagulant drug/s during CRRT.PMID:34240632 | DOI:10.1177/03913988211031253

Source: The International Journal of Artificial Organs - July 9, 2021 Category: Transplant Surgery Authors: Vivek Gupta Naved Aslam Shibba Takkar Chhabra Vikas Makkar Bishav Mohan Samir Kapoor Vikram Pal Singh Rajiv Kumar Suvir Grover Gurkirat Kaur Suman Sethi Simran Kaur Abhishek Goyal Bhupinder Singh Gurbhej Singh Sarju Ralhan Gurpreet Singh Wander Source Type: research